Xtl Biopharmaceuticals (XTLB) Cash Due from Bank (2012 - 2016)
Xtl Biopharmaceuticals (XTLB) reported Cash Due from Bank of $2.02 million for the quarter ended Dec 31, 2016, down 47.1% from $3.82 million a year earlier and down 13.0% from the prior quarter.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Cash Due from Bank (2012 - 2016) Analysis & Trends
Dating back to the quarter ended Dec 31, 2012, Xtl Biopharmaceuticals' Cash Due from Bank record includes 13 quarters.
- Cash Due from Bank has a four-year compound annual growth rate of -11.6% (years ended Dec 2012 to Dec 2016).
- By year, Cash Due from Bank came in at $3.82 million in the year ended Dec 31, 2015 (+76.8%), $2.16 million in the year ended Dec 31, 2014 (-48.2%), $4.17 million in the year ended Dec 31, 2013 (+25.8%) and $3.31 million in the year ended Dec 31, 2012.
- The figure for the quarter ended Dec 31, 2016 ranks as the lowest quarterly Cash Due from Bank since the quarter ended Mar 31, 2015.
- Year over year, Cash Due from Bank gained in four of the last seven quarters, with growth averaging 22.4%.
- The high point for year-over-year Cash Due from Bank in five years was the quarter ended Jun 30, 2015 (growth of 80.1%); the low point was the quarter ended Dec 31, 2014 (a decline of 48.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash Due from Bank (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | - |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | - |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Xtl Biopharmaceuticals | 2.13 Bn | 2.13 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2016 | 2.02 Mn |
| Sep 30, 2016 | 2.32 Mn |
| Mar 31, 2016 | 3.11 Mn |
| Dec 31, 2015 | 3.82 Mn |
| Sep 30, 2015 | 4.30 Mn |
| Jun 30, 2015 | 4.82 Mn |
| Mar 31, 2015 | 1.75 Mn |
| Dec 31, 2014 | 2.16 Mn |
| Sep 30, 2014 | 2.91 Mn |
| Jun 30, 2014 | 2.68 Mn |
| Mar 31, 2014 | 2.60 Mn |
| Dec 31, 2013 | 4.17 Mn |
| Dec 31, 2012 | 3.31 Mn |
API Access
Xtl Biopharmaceuticals Cash Due from Bank API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-due-from-bank&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-due-from-bank", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-due-from-bank&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();